8/19/2019 Sample Transcript

1/1

{0:01:12 0:02:08}

I did a SWOT analysis of Incare Pharmaceuticals and Healthcare Industry. The slide shows

my findings.

Strengths: United States is the largest market in North merica in !"#$. United States is

one of North merica%s most de&elo'ed markets( and regulatory standards are su'erior to

most of its southern neigh)ors. United States has strong trade links outside North merica

to the U.S.( *anada( and +U. United States has a com'etiti&e and well,de&elo'ed

'harmaceutical industry including around !"" com'anies and a su)stantial multinational

'resence.

{0:02:10 0:03:06}

Weaknesses: -es'ite im'ortant recent reforms( the enforcement of domestic 'atent law

remains 'ro)lematic( and counterfeiting is a continuing 'ro)lem. With nearly half of the

'o'ulation lacking health insurance( United States%s drug market is 'articularly sensiti&e to

economic shocks. The e/ican go&ernment%s drug,'ricing 'olicy is focusing on cost

containment( while an inefficient su''ly chain leads to high 'rices for consumers. The

e/'ansion of state health co&erage has focused on )asic essential drugs( and

reim)ursement for many hi,tech im'orted drugs remains limited or none/istent.

{0:03:08 0:04:04}

O''ortunities: The generics market has strong growth 'otential as )oth( the go&ernment

and consumers looks to the sector to 'ro&ide cost,effecti&e co&erage in 'lace of less relia)le

co'y drugs. New legislation on )ioe0ui&alence has recently )een a''ro&ed